期刊文献+

糖尿病肾病早期应用肾素血管紧张素阻滞剂治疗进展 被引量:2

下载PDF
导出
摘要 糖尿病肾病(diabetic nephropathy,DN)是糖尿病(diabetesmellitus,DM)最常见的微血管并发症之一,也是DM患者终末期肾衰竭的主要原因。美国2009年的数据显示由DM导致的终末期肾病(end-stagerenaldisease,ESRD)占ESRD需要透析治疗患者的54%。一旦发生DN,其进展至终末期肾衰竭的速度比一般肾脏疾病快14倍之多。
作者 黄艳 陈海冰
出处 《临床肾脏病杂志》 2012年第9期430-432,共3页 Journal Of Clinical Nephrology
基金 国家自然科学基金(81070649)
  • 相关文献

参考文献15

  • 1Katayama S. Is Renoprotection by Angiotensin Receptor BlockerDependent on Blood Pressure? The Saitama Medical School, Al-buminuria Reduction in Diabetics with Valsartan(STAR)Study.Hypertens Res,2007,30:529-533.
  • 2Fukutomi M,Hoshide S, Eguchi K,et al. Differential effects ofstrict blood pressure lowering by losartan/hydrochlorothiazidecombination therapy and high-dose amlodipine monotherapy onmicroalbuminuria:The ALPHABET study. J Am Soc Hypertens,2012,6:73-82.
  • 3Makino H?Haneda M, Babazono T, et al. Microalbuminuria re-duction with telmisartan in normotensive and hypertensive Japa-nese patients with type 2 diabetes: A post-hoc analysis of The In-cipient to Overt: Angiotensin II Blocker, Telmisartan, Investiga-tion on Type 2 Diabetic Nephropathy (INNOVATION) study.Hypertens Res,2008,31:657-664.
  • 4Anantharaman R,Bhansali A? Bhadada SK,et al. Anti-albumin-uric efficacy of a combination of angiotensin converting enzymeinhibitor & angiotensin receptor blocker in type 1 DM with ne-phropathy. Indian J Med Res,2010,132:42-47.
  • 5Schmieder RE, Bakris G? Weir MR. Telmisartan in incipient andovert diabetic renal disease. J Nephrol ?2011,24: 263-273.
  • 6Haller H,Ito S,Izzo JL,et al. Olmesartan for the delay or preven-tion of microalbuminuria in type 2 diabetes. N Engl J Med,2011,364:907-917.
  • 7Grassi G. The ROADMAP trial:Olmesartan for the delay or pre-vention of microalbuminuria in type 2 diabetes. Expert OpinPharmacother?2011,12:2421-2424.
  • 8Krairittichai U, Chaisuvannarat V. Effects of Dual Blockade ofRenin-Angiotensin System in Type 2 Diabetes Mellitus Patientswith Diabetic Nephropathy. J Med Assoc Thai,2009,92: 611-617.
  • 9Dong YF,Liu L,Lai ZF,et al. Aliskiren enhances protectiveeffects of valsartan against type 2 diabetic nephropathy in mice. JHypertens, 2010,28 : 1554-1565.
  • 10Parving HH,Persson F,Lewis JB,et al. Aliskiren combined withlosartan in type 2 diabetes and nephropathy. N Engl J Med,2008,358:2433-2446.

同被引文献17

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部